Terry M Therneau

Author PubWeight™ 244.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003 9.96
2 A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002 8.63
3 Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006 7.24
4 The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007 6.68
5 Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008 6.67
6 Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 2007 6.07
7 Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet 2010 4.75
8 Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005 4.48
9 POEMS syndrome: definitions and long-term outcome. Blood 2002 4.35
10 Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010 3.84
11 Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004 3.43
12 Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol 2009 3.42
13 Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 2004 2.97
14 Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003 2.89
15 Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood 2007 2.87
16 Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 2011 2.74
17 Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003 2.68
18 Clinical course of patients with relapsed multiple myeloma. Mayo Clin Proc 2004 2.62
19 Serum aminotransferase activity and mortality risk in a United States community. Hepatology 2008 2.61
20 Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis 2010 2.54
21 Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012 2.44
22 Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc 2004 2.43
23 Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007 2.36
24 Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology 2012 2.33
25 Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics 2004 2.31
26 Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer 2004 2.31
27 The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007 2.25
28 Sudden death after myocardial infarction. JAMA 2008 2.24
29 A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004 2.23
30 High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum 2008 2.14
31 3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics 2009 2.12
32 Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 2008 2.07
33 Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013 2.03
34 Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol 2008 2.02
35 Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011 2.01
36 Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004 2.01
37 A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology 2011 1.99
38 Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 2006 1.98
39 The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008 1.94
40 Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006 1.93
41 The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 2011 1.91
42 Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood 2009 1.90
43 Autoantibodies and the risk of cardiovascular events. J Rheumatol 2009 1.89
44 Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 2009 1.88
45 Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004 1.87
46 Batch effect correction for genome-wide methylation data with Illumina Infinium platform. BMC Med Genomics 2011 1.84
47 The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 2011 1.82
48 Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology 2014 1.75
49 Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012 1.69
50 Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007 1.67
51 Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res 2008 1.67
52 Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 2010 1.67
53 A statistical model for iTRAQ data analysis. J Proteome Res 2008 1.67
54 A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol 2004 1.66
55 Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003 1.64
56 Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol 2010 1.62
57 Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem 2011 1.57
58 Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol 2009 1.51
59 How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005 1.49
60 Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011 1.49
61 Underestimation of liver-related mortality in the United States. Gastroenterology 2013 1.46
62 The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology 2004 1.42
63 Random-effects Cox proportional hazards model: general variance components methods for time-to-event data. Genet Epidemiol 2005 1.42
64 A partially linear tree-based regression model for assessing complex joint gene-gene and gene-environment effects. Genet Epidemiol 2007 1.40
65 Changing epidemiology of hepatitis B in a U.S. community. Hepatology 2004 1.35
66 Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology 2009 1.35
67 Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol 2004 1.33
68 Relation of vertebral deformities to bone density, structure, and strength. J Bone Miner Res 2010 1.32
69 Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 2005 1.27
70 Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2009 1.27
71 A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters. Mol Cell Proteomics 2006 1.27
72 Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol 2008 1.26
73 Assessing fracture risk using gradient boosting machine (GBM) models. J Bone Miner Res 2012 1.24
74 Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010 1.22
75 Coronary revascularization in the community. A population-based study, 1990 to 2004. J Am Coll Cardiol 2007 1.21
76 Calculating sample size estimates for RNA sequencing data. J Comput Biol 2013 1.21
77 Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. Mayo Clin Proc 2012 1.14
78 Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications. Blood 2010 1.13
79 The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol 2007 1.13
80 Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia. Br J Haematol 2006 1.11
81 Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol 2012 1.09
82 Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population. Mayo Clin Proc 2012 1.09
83 Association of hip strength estimates by finite-element analysis with fractures in women and men. J Bone Miner Res 2011 1.07
84 Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl 2015 1.06
85 Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol 2014 1.06
86 Progression in smoldering Waldenstrom macroglobulinemia: long-term results. Blood 2012 1.06
87 Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. Am J Gastroenterol 2012 1.05
88 Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol 2010 1.04
89 Fracture risk in women with breast cancer: a population-based study. J Bone Miner Res 2012 1.03
90 Donor race does not predict graft failure after liver transplantation. Gastroenterology 2010 1.03
91 Technical and biological variance structure in mRNA-Seq data: life in the real world. BMC Genomics 2012 1.03
92 Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides. J Proteome Res 2011 1.02
93 Neighborhood income and individual education: effect on survival after myocardial infarction. Mayo Clin Proc 2008 1.01
94 Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010 1.01
95 The kinship2 R package for pedigree data. Hum Hered 2014 1.00
96 Fracture risk in men with prostate cancer: a population-based study. J Bone Miner Res 2011 1.00
97 Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays. Cancer Res 2005 0.99
98 Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009 0.99
99 Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol 2010 0.98
100 Impact of the center on graft failure after liver transplantation. Liver Transpl 2013 0.98
101 The effect of static stretching of the calf muscle-tendon unit on active ankle dorsiflexion range of motion. J Orthop Sports Phys Ther 2003 0.98
102 Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology 2012 0.97
103 Proximal femoral density distribution and structure in relation to age and hip fracture risk in women. J Bone Miner Res 2013 0.97
104 A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis. Bioinformatics 2013 0.96
105 Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue. Epigenetics 2012 0.95
106 Primer: Demystifying risk--understanding and communicating medical risks. Nat Clin Pract Rheumatol 2007 0.95
107 Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation. Liver Transpl 2014 0.95
108 Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis. Amyloid 2005 0.93
109 SERE: single-parameter quality control and sample comparison for RNA-Seq. BMC Genomics 2012 0.92
110 Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol 2013 0.91
111 Quantitating tissue specificity of human genes to facilitate biomarker discovery. Bioinformatics 2007 0.90
112 Alcohol intake in adolescence and mammographic density. Int J Cancer 2005 0.90
113 Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis? Arthritis Rheum 2010 0.89
114 A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum 2011 0.88
115 Joint estimation of calibration and expression for high-density oligonucleotide arrays. Bioinformatics 2006 0.88
116 Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clin Proc 2012 0.88
117 Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance. Clin Lymphoma 2005 0.87
118 Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples. BMC Res Notes 2013 0.85
119 Plasticity of DNA methylation in a nerve injury model of pain. Epigenetics 2015 0.83
120 Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum 2013 0.83
121 Global tests in the additive hazards regression model. Stat Med 2008 0.82
122 Employment and health insurance in long-term liver transplant recipients. Am J Transplant 2005 0.81
123 Structural patterns of the proximal femur in relation to age and hip fracture risk in women. Bone 2013 0.81
124 Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 2011 0.81
125 Performance of an item response theory-based computer adaptive test in identifying functional decline. Arch Phys Med Rehabil 2012 0.81
126 A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther 2012 0.80
127 Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma. Br J Haematol 2012 0.79
128 Bi-Linear Regression for O Quantification: Modeling across the Elution Profile. J Proteomics Bioinform 2010 0.79
129 RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1. Acta Oncol 2014 0.79
130 Potential Extensions of the US FRAX Algorithm. J Osteoporos 2012 0.78
131 Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity. Arthritis Res Ther 2013 0.78
132 Spatial normalization improves the quality of genotype calling for Affymetrix SNP 6.0 arrays. BMC Bioinformatics 2010 0.78
133 Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemia. Clin Lymphoma Myeloma Leuk 2013 0.78
134 Predictors of excess mortality after fracture: a population-based cohort study. J Bone Miner Res 2014 0.78
135 Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum 2013 0.78
136 Insights on the robust variance estimator under recurrent-events model. Biometrics 2011 0.78
137 Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation 2015 0.77
138 Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis. Clin Immunol 2011 0.77
139 Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007. Arthritis Care Res (Hoboken) 2014 0.77
140 Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging. J Alzheimers Dis 2015 0.76
141 Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 2002 0.75
142 Reply: To PMID 23055147. Hepatology 2013 0.75
143 Statistical metrics for quality assessment of high-density tiling array data. Biometrics 2009 0.75
144 Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Mayo Clin Proc 2010 0.75
145 Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study. Cancer Detect Prev 2003 0.75
146 Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis C. Hepatol Res 2006 0.75